DK1474422T3 - R-(-)-1-[2-(7-chlorbenzo[b]thiophen-3-ylmethoxy)-2-(2,4-dichlorphenyl)ethyl]-1H imidazol - Google Patents

R-(-)-1-[2-(7-chlorbenzo[b]thiophen-3-ylmethoxy)-2-(2,4-dichlorphenyl)ethyl]-1H imidazol

Info

Publication number
DK1474422T3
DK1474422T3 DK03702597T DK03702597T DK1474422T3 DK 1474422 T3 DK1474422 T3 DK 1474422T3 DK 03702597 T DK03702597 T DK 03702597T DK 03702597 T DK03702597 T DK 03702597T DK 1474422 T3 DK1474422 T3 DK 1474422T3
Authority
DK
Denmark
Prior art keywords
thiophen
imidazole
ethyl
chlorobenzo
ylmethoxy
Prior art date
Application number
DK03702597T
Other languages
Danish (da)
English (en)
Inventor
Rafael Foguet
Celia Palacin
Luis Anglada
Antonio Guglietta
Jorge Ramentol
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Int filed Critical Ferrer Int
Application granted granted Critical
Publication of DK1474422T3 publication Critical patent/DK1474422T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK03702597T 2002-02-11 2003-02-04 R-(-)-1-[2-(7-chlorbenzo[b]thiophen-3-ylmethoxy)-2-(2,4-dichlorphenyl)ethyl]-1H imidazol DK1474422T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200200328A ES2203316B1 (es) 2002-02-11 2002-02-11 R-(-)-1-(2-(7-cloro-benzo(b)tiofen-3-il-metoxi)-2-(2,4-dicloro-fenil)-etil)1h-imidazol.
PCT/EP2003/001089 WO2003068770A1 (en) 2002-02-11 2003-02-04 R- (-) -1- [2- (7-CHLOROBENZO [b] THIOPHEN-3 -YL- METHOXY) -2- (2,4-DICHLOROPHENYL) -ETHYL] -1H-IMIDAZOLE

Publications (1)

Publication Number Publication Date
DK1474422T3 true DK1474422T3 (da) 2008-05-13

Family

ID=27675919

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03702597T DK1474422T3 (da) 2002-02-11 2003-02-04 R-(-)-1-[2-(7-chlorbenzo[b]thiophen-3-ylmethoxy)-2-(2,4-dichlorphenyl)ethyl]-1H imidazol

Country Status (25)

Country Link
US (1) US7323433B2 (de)
EP (1) EP1474422B1 (de)
JP (1) JP5095070B2 (de)
KR (1) KR100701457B1 (de)
CN (1) CN1315824C (de)
AT (1) ATE382618T1 (de)
AU (1) AU2003205733B8 (de)
BR (1) BR0307754A (de)
CA (1) CA2474627C (de)
CO (1) CO5601026A2 (de)
DE (1) DE60318395T2 (de)
DK (1) DK1474422T3 (de)
ES (1) ES2203316B1 (de)
HK (1) HK1070883A1 (de)
IL (1) IL163452A (de)
MX (1) MXPA04007581A (de)
NO (1) NO327937B1 (de)
NZ (1) NZ534464A (de)
PL (1) PL211168B1 (de)
PT (1) PT1474422E (de)
RU (1) RU2276152C1 (de)
TN (1) TNSN04140A1 (de)
UA (1) UA78010C2 (de)
WO (1) WO2003068770A1 (de)
ZA (1) ZA200405941B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2249992B1 (es) * 2004-09-13 2007-03-01 Ferrer Internacional, S.A. Un procedimiento para fabricar compuestos enantiomericos del imidazol.
ES2249991B1 (es) * 2004-09-13 2007-03-01 Ferrer Internacional, S.A. Procedimiento de fabricacion de compuestos imidazolicos, sus sales y sus pseudopolimorfos.
EP1698336A1 (de) * 2005-03-01 2006-09-06 Ferrer Internacional, S.A. Antimykotischezusammensetzungen enthaltend Sertaconazol und entweder Hydrokortison oder einen antibakteriellen Wikrstoff
WO2010066756A1 (en) * 2008-12-09 2010-06-17 Ferrer Internacional, S.A. Polymorph ii of an antifungal compound
EP2436374A1 (de) * 2010-09-30 2012-04-04 Ferrer Internacional, S.A. Ovulus zur vaginalen Verabreichung von Arasertaconazol
EP2551351A1 (de) 2011-07-29 2013-01-30 Interquim, S.A. Verfahren zur Herstellung von optisch aktivem (R)-(-)-1-(2,4-dichlor-phenyl)-2-imidazol-1-yl-ethanol
CN102440947B (zh) * 2011-11-15 2012-12-26 海南海神同洲制药有限公司 硝酸舍他康唑乳膏剂
KR101717968B1 (ko) 2016-07-18 2017-03-20 씨앤아이 주식회사 스마트폰 결합 모듈
CN113480517B (zh) * 2021-07-30 2022-09-09 海南海神同洲制药有限公司 3-溴甲基-7-氯苯并[b]噻吩的合成方法
CN113735843B (zh) * 2021-09-07 2023-05-26 海南海神同洲制药有限公司 一种低熔点硝酸舍他康唑的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1250586A (en) * 1984-02-02 1989-02-28 Manuel Raga 1h-imidazole derivatives and process for their production
US5135943A (en) * 1984-02-02 1992-08-04 Ferrer Internacional S.A. 1H-imidazole derivative compounds and pharmaceutical compositions containing the same
US5087620A (en) * 1990-05-17 1992-02-11 Bristol-Myers Squibb Co. Controlled dermal penetration enhancement using imidazoles
ES2120720T3 (es) * 1995-01-04 1998-11-01 Ferrer Int Procedimiento de obtencion de los polimeros b y c de mononitrato de 1-(2,4-dicloro-beta-((7-clorobenzo(b)tien-3-il)metoxi)fenetil)imidazol.

Also Published As

Publication number Publication date
JP2005524639A (ja) 2005-08-18
EP1474422A1 (de) 2004-11-10
PL211168B1 (pl) 2012-04-30
JP5095070B2 (ja) 2012-12-12
UA78010C2 (uk) 2007-02-15
IL163452A (en) 2011-11-30
ES2203316A1 (es) 2004-04-01
PL370251A1 (en) 2005-05-16
CN1315824C (zh) 2007-05-16
KR20040079996A (ko) 2004-09-16
AU2003205733B8 (en) 2008-09-04
ATE382618T1 (de) 2008-01-15
RU2004127573A (ru) 2006-02-10
MXPA04007581A (es) 2004-11-10
EP1474422B1 (de) 2008-01-02
DE60318395T2 (de) 2009-01-02
HK1070883A1 (en) 2005-06-30
TNSN04140A1 (en) 2007-03-12
DE60318395D1 (de) 2008-02-14
CO5601026A2 (es) 2006-01-31
KR100701457B1 (ko) 2007-03-29
CA2474627C (en) 2009-09-22
NZ534464A (en) 2006-02-24
WO2003068770A1 (en) 2003-08-21
BR0307754A (pt) 2004-12-07
RU2276152C1 (ru) 2006-05-10
ES2203316B1 (es) 2005-03-01
PT1474422E (pt) 2008-02-28
NO327937B1 (no) 2009-10-26
AU2003205733B2 (en) 2008-08-14
AU2003205733A1 (en) 2003-09-04
CN1630654A (zh) 2005-06-22
ZA200405941B (en) 2006-07-26
NO20043377L (no) 2004-08-13
US20050065201A1 (en) 2005-03-24
US7323433B2 (en) 2008-01-29
CA2474627A1 (en) 2003-08-21

Similar Documents

Publication Publication Date Title
HK1070883A1 (en) R-(-)-1-2-(7-chlorobenzo-b-thiophen-3-yl-methoxy)-2(2,4-dichlorophenyl)ethyl-1h-imidazole
RS20060173A (en) Use of fungicides for disinfecting cereal seed
WO2004016086A3 (en) 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
HUP0203563A2 (hu) Fungicid hatású, aktív vegyületkombináció és alkalmazása
BR9809100B1 (pt) composições fungicidas, processo para sua preparação, aplicação das mesmas e processo para combater fungos.
CY1109242T1 (el) Θεραπευτικοι παραγοντες χρησιμοι για θεραπεια πονου
HUP9901550A2 (hu) Növényimmunizáló hatású benzotiadiazolszármazékot tartalmazó szinergetikus fungicid készítmények és alkalmazásuk
SK8142000A3 (en) Fungicide mixtures based on amide compounds and azoles
KR930011820A (ko) 살균제
PT884997E (pt) Composicoes contendo um fungicida e um composto sulfurado
AR071458A1 (es) Composiciones fungicidas con 3'-bromo-2,3,4,6'-tetrametoxi-2',6-dimetilbenzofenona
WO2001066551A8 (en) Azole compounds as therapeutic agents for fungal infections
MXPA04004557A (es) Composicion fungicida basada en derivado de piridilmetilbenzamida y derivado de valinamida.
EA201891044A1 (ru) Комбинации активных соединений, содержащие производное (тио)карбоксамида и фунгицидное соединение
AU2018285656A1 (en) Stabilised formulations containing prothioconazole with a low 2-(1-chlorocyclopropyl)-1-(2-chlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ol content
EA200100586A1 (ru) Применение производных фосфономуравьиной кислоты для лечения инфекций
WO2000016757A8 (de) Verwendung von phosphororganischen verbindungen zur herstellung von arzneimitteln zur therapeutischen und prophylaktischen behandlung von infektionen oder als fungizid, bakterizid oder herbizid bei pflanzen
AR002150A1 (es) Composiciones fungicidas que contienen 8-t-butil-2-(n-etil-n-n-propilamino) -metil-1,4-dioxaespiro[5,4] decano, tebuconazol y propiconazol, procedimientopara la obtencion de dichas composiciones y procedimientos para la lucha contra hongos.
WO2002080669A3 (en) Use of alpha2-adrenergic receptor agonists and adrenergic inhibitors in reducing defoliation
WO2002055022A3 (en) Active metabolite of antifungal compound
BR0206494A (pt) Misturas fungicidas e método para combater fungos nocivos
MX2021011359A (es) Formulaciones estabilizadas de tiocetonas.
BG104259A (en) Derivatives of 4-cyano-4-deformylsordaricin
AP2001002164A0 (en) Use of phosphonoformic acid derivatives for treating infections.
RU2000123391A (ru) Производные триазола, обладающие противогрибковой активностью